Prasanna Sivaprakasam

Author

Bristol-Myers Squibb (United States)ORCID

Also Known As

Prasanna Sivaprakasam, S Prasanna, S. PRASANNA, S. Prasanna, S.M. Prasanna, Sivaprakasam Prasanna, Sridevi Prasanna

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Mississippi Biocon (India)Devi Ahilya Vishwavidyalaya Bristol-Myers Squibb (India)

About

Prasanna Sivaprakasam is an author at Bristol-Myers Squibb (United States) specializing in medicine, medicinal chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	393
2	Natural Sciences	8	8	322
3	Biochemistry	8	8	322
4	Chemical Biology	4	4	193
5	Chemistry	1	1	16

Prasanna Sivaprakasam

Publications

690

Citations

H-Index

Page 1

	Year	Citations
Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core Prasanna Sivaprakasam, Xiaojun Han, Rita L. Civiello, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryNatural SciencesMedicine	2015	114
Structure−Activity Relationship and Mechanism of Action Studies of Manzamine Analogues for the Control of Neuroinflammation and Cerebral Infections Jiangnan Peng, Sucheta Kudrimoti, Prasanna Sivaprakasam, Journal of Medicinal Chemistry	2009	90
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors Guanglin Luo, Ling Chen, Catherine R. Burton, Journal of Medicinal Chemistry Chemoprevention StrategyKinase-selective Gsk-3 InhibitorsPharmacotherapyMedicinal ChemistryReceptor Tyrosine Kinase	2016	68
Homology models of the <scp>HIV</scp>‐1 attachment inhibitor <scp>BMS</scp>‐626529 bound to gp120 suggest a unique mechanism of action David R. Langley, S. Roy Kimura, Prasanna Sivaprakasam, Proteins Structure Function and Bioinformatics Signal TransductionHiv-1 Gp120Protein FoldingUnlig ConformationMedicine	2014	58
Probing the physicochemical and structural requirements for glycogen synthase kinase-3α inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides Prasanna Sivaprakasam, Aihua Xie, Robert J. Doerksen Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryStructural RequirementsNatural SciencesMolecular Biology	2006	43
Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapy Naidu S. Chowdari, Chin Pan, Chetana Rao, Bioorganic & Medicinal Chemistry Letters Drug TargetingTargeted Cancer TherapyMedicinePolymer-drug ConjugatePharmacology	2018	32
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors Li Guo, Nicholas A. Meanwell, Mark Krystal, Journal of Medicinal Chemistry	2020	27
Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors Richard A. Hartz, Vijay T. Ahuja, Prasanna Sivaprakasam, Journal of Medicinal Chemistry	2023	27
Structure−Activity Relationship and Comparative Docking Studies for Cycloguanil Analogs as PfDHFR-TS Inhibitors Prasanna Sivaprakasam, Perrer N. Tosso, Robert J. Doerksen Journal of Chemical Information and Modeling	2009	25
2-N-Methyl modifications and SAR studies of manzamine A Mohamed A. Ibrahim, Abbas Gholipour Shilabin, Prasanna Sivaprakasam, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicineMass SpectrometryStructure ElucidationOrganic Chemistry	2008	24

Page 1